Factors associated with health-related cannabis use intentions among a community sample of people who inject drugs in Los Angeles and San Francisco, CA 2016 to 2018

被引:4
作者
Ceasar, Rachel Carmen [1 ]
Kral, Alex H. [2 ]
Simpson, Kelsey [1 ]
Wenger, Lynn [2 ]
Goldshear, Jesse L. [1 ]
Bluthenthal, Ricky N. [1 ]
机构
[1] Univ Southern Calif, Dept Prevent Med, Keck Sch Med, 2001 N Soto St, Los Angeles, CA 90032 USA
[2] RTI Int, Behav Hlth Res Div, 2150 Shattuck Ave,Suite 800, Berkeley, CA 94704 USA
关键词
Cannabis; Motivation; Opioids; Substance use; People who inject drugs; Self-treatment; Pain; Mental health; Harm reduction; MEDICAL MARIJUANA LEGALIZATION; NON-PRESCRIBED USE; CANNOT TELL US; NONFATAL OVERDOSE; RECREATIONAL CANNABIS; PRESCRIPTION OPIOIDS; PHYSICAL ABUSE; UNITED-STATES; PAIN; RISK;
D O I
10.1016/j.drugalcdep.2020.108421
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: Cannabis motivations have been studied extensively among patients of medicinal cannabis dispensaries, but less is known about motivations in community samples of opioid-using people who inject drugs. Our objective is to describe cannabis use motivations associated with self-treatment of physical pain, emotional issues, and as an opioid substitute. Methods: Data come from 6-month follow-up interviews with people who inject drugs who participated in a study on the efficacy of an injection initiation prevention intervention in Los Angeles and San Francisco, California from 2016-18. The analytic sample consists of 387 people who inject drugs who reported past-month cannabis use. We developed multivariable logistic regression models by reported cannabis use motivations: physical pain relief, emotional problems, and opioid substitute. Results: The most common cannabis use motivations reported by people who inject drugs was to "get high," relieve physical pain and emotional problems, and reduce opioid use. In separate multivariate models, using cannabis for physical pain relief was associated with higher odds of using cannabis as a substitute for opioids; cannabis for emotional problems was associated with being diagnosed with depression; and cannabis as a substitute for opioids was associated with non-prescribed, non-injection methadone use. Conclusion: People who inject drugs reported using cannabis for health-related motivations. This motivation aligns with health needs and suggests the acceptability of cannabis use for health reasons in this population. Studies to determine the medical effectiveness of cannabis products for these common health and mental health needs among people who inject drugs are needed.
引用
收藏
页数:8
相关论文
共 91 条
  • [1] Licit and illicit substance use among people who inject drugs and the association with subsequent suicidal attempt
    Artenie, Andreea Adelina
    Bruneau, Julie
    Roy, Elise
    Zang, Geng
    Lesperance, Francois
    Renaud, Johanne
    Tremblay, Joel
    Jutras-Aswad, Didier
    [J]. ADDICTION, 2015, 110 (10) : 1636 - 1643
  • [2] Medical Reasons for Marijuana Use, Forms of Use, and Patient Perception of Physician Attitudes Among the US Population
    Azcarate, Patrick M.
    Zhang, Alysandra J.
    Keyhani, Salomeh
    Steigerwald, Stacey
    Ishida, Julie H.
    Cohen, Beth E.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (07) : 1979 - 1986
  • [3] What Ecologic Analyses Cannot Tell Us About Medical Marijuana Legalization and Opioid Pain Medication Mortality Reply
    Bachhuber, Marcus A.
    Saloner, Brendan
    Barry, Colleen L.
    [J]. JAMA INTERNAL MEDICINE, 2015, 175 (04) : 656 - 657
  • [4] Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
    Bachhuber, Marcus A.
    Saloner, Brendan
    Cunningham, Chinazo O.
    Barry, Colleen L.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (10) : 1668 - 1673
  • [5] Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
    Baron, Eric P.
    Lucas, Philippe
    Eades, Joshua
    Hogue, Olivia
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [6] Characterization of the Emerging HIV Type 1 and HCV Epidemics among Injecting Drug Users in Dushanbe, Tajikistan
    Beyrer, Chris
    Patel, Zeenat
    Stachowiak, Julie A.
    Tishkova, Farida K.
    Stibich, Mark A.
    Eyzaguirre, Lindsay M.
    Carr, Jean K.
    Mogilnii, Vladimir
    Peryshkina, Alena
    Latypov, Alisher
    Strathdee, Steffanie A.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (09) : 853 - 860
  • [7] Bluthenthal R N, 1995, NIDA Res Monogr, V157, P212
  • [8] Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs
    Bluthenthal, Ricky N.
    Simpson, Kelsey
    Ceasar, Rachel Carmen
    Zhao, Johnathan
    Wenger, Lynn
    Kral, Alex H.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2020, 211
  • [9] Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain
    Boehnke, Kevin F.
    Litinas, Evangelos
    Clauw, Daniel J.
    [J]. JOURNAL OF PAIN, 2016, 17 (06) : 739 - 744
  • [10] The use of cannabis for management of chronic pain
    Bostwick, J. Michael
    [J]. GENERAL HOSPITAL PSYCHIATRY, 2014, 36 (01) : 2 - 3